Millennium Pharmacon International Stock Market Capitalization
SDPC Stock | IDR 144.00 1.00 0.69% |
Millennium Pharmacon International fundamentals help investors to digest information that contributes to Millennium Pharmacon's financial success or failures. It also enables traders to predict the movement of Millennium Stock. The fundamental analysis module provides a way to measure Millennium Pharmacon's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Millennium Pharmacon stock.
Millennium |
Millennium Market Capitalization Analysis
Millennium Pharmacon's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Millennium Pharmacon Market Capitalization | 440.8 B |
Most of Millennium Pharmacon's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Millennium Pharmacon International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Based on the recorded statements, the market capitalization of Millennium Pharmacon International is about 440.8 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The market capitalization for all Indonesia stocks is significantly lower than that of the firm.
Millennium Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Millennium Pharmacon's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Millennium Pharmacon could also be used in its relative valuation, which is a method of valuing Millennium Pharmacon by comparing valuation metrics of similar companies.Millennium Pharmacon is currently under evaluation in market capitalization category among related companies.
Millennium Fundamentals
Return On Equity | 0.0938 | |||
Return On Asset | 0.0342 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 828.27 B | |||
Shares Outstanding | 1.27 B | |||
Shares Owned By Insiders | 87.94 % | |||
Shares Owned By Institutions | 3.35 % | |||
Price To Earning | 9.31 X | |||
Price To Book | 1.16 X | |||
Price To Sales | 0.10 X | |||
Revenue | 2.99 T | |||
Gross Profit | 237.04 B | |||
EBITDA | 73.6 B | |||
Net Income | 9.57 B | |||
Cash And Equivalents | 43.62 B | |||
Cash Per Share | 34.24 X | |||
Total Debt | 1.8 B | |||
Debt To Equity | 257.80 % | |||
Current Ratio | 1.15 X | |||
Book Value Per Share | 202.66 X | |||
Cash Flow From Operations | (18.18 B) | |||
Earnings Per Share | 19.19 X | |||
Number Of Employees | 1.09 K | |||
Beta | 0.75 | |||
Market Capitalization | 440.8 B | |||
Total Asset | 1.21 T | |||
Annual Yield | 0 % | |||
Net Asset | 1.21 T | |||
Last Dividend Paid | 1.0 |
About Millennium Pharmacon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Millennium Pharmacon International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Millennium Pharmacon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Millennium Pharmacon International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Currently Active Assets on Macroaxis
ABBV | AbbVie Inc | |
HBI | Hanesbrands | |
MIDU | Direxion Daily Mid | |
V | Visa Class A | |
ORCL | Oracle |
Check out Millennium Pharmacon Piotroski F Score and Millennium Pharmacon Altman Z Score analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |